LPL Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.4M Buy
31,932
+863
+3% +$68.1K ﹤0.01% 3332
2025
Q4
$2.46M Buy
31,069
+6,606
+27% +$497K ﹤0.01% 3201
2025
Q3
$1.6M Sell
24,463
-409
-2% -$20K ﹤0.01% 3530
2025
Q2
$983K Buy
24,872
+906
+4% +$29.6K ﹤0.01% 3776
2025
Q1
$723K Sell
23,966
-16,410
-41% -$537K ﹤0.01% 3820
2024
Q4
$1.41M Sell
40,376
-2,244
-5% -$83.9K ﹤0.01% 3193
2024
Q3
$1.71M Sell
42,620
-8,794
-17% -$409K ﹤0.01% 2887
2024
Q2
$2.45M Sell
51,414
-28,308
-36% -$1.16M ﹤0.01% 2428
2024
Q1
$3.46M Sell
79,722
-7,577
-9% -$361K ﹤0.01% 2071
2023
Q4
$4.42M Buy
87,299
+5,483
+7% +$263K ﹤0.01% 1763
2023
Q3
$3.71M Sell
81,816
-219
-0.3% -$9.04K ﹤0.01% 1782
2023
Q2
$3.37M Buy
82,035
+13,041
+19% +$501K ﹤0.01% 1826
2023
Q1
$2.47M Sell
68,994
-5,105
-7% -$192K ﹤0.01% 1977
2022
Q4
$2.8M Sell
74,099
-641
-0.9% -$27K ﹤0.01% 1818
2022
Q3
$3.31M Sell
74,740
-7,347
-9% -$310K ﹤0.01% 1651
2022
Q2
$3.04M Sell
82,087
-12,466
-13% -$470K ﹤0.01% 1715
2022
Q1
$3.5M Buy
94,553
+5,887
+7% +$193K ﹤0.01% 1654
2021
Q4
$2.7M Buy
88,666
+5,051
+6% +$159K ﹤0.01% 1870
2021
Q3
$2.8M Buy
83,615
+24,299
+41% +$916K ﹤0.01% 1798
2021
Q2
$2.37M Buy
59,316
+4,033
+7% +$158K ﹤0.01% 1836
2021
Q1
$2.49M Buy
55,283
+2,204
+4% +$123K ﹤0.01% 1690
2020
Q4
$3M Buy
53,079
+3,222
+6% +$161K ﹤0.01% 1413
2020
Q3
$2.37M Buy
49,857
+3,664
+8% +$204K ﹤0.01% 1367
2020
Q2
$2.72M Sell
46,193
-655
-1% -$36.4K ﹤0.01% 1182
2020
Q1
$2.21M Buy
46,848
+796
+2% +$44.4K ﹤0.01% 1134
2019
Q4
$2.78M Sell
46,052
-43
-0.1% -$2.56K 0.01% 1150
2019
Q3
$2.76M Buy
46,095
+241
+0.5% +$15.7K 0.01% 1073
2019
Q2
$2.95M Buy
45,854
+1,478
+3% +$104K 0.01% 1028
2019
Q1
$3.6M Sell
44,376
-851
-2% -$54.9K 0.01% 903
2018
Q4
$2.44M Buy
45,227
+714
+2% +$36.4K 0.01% 975
2018
Q3
$2.3M Sell
44,513
-1,343
-3% -$63.1K 0.01% 1092
2018
Q2
$1.91M Sell
45,856
-244
-0.5% -$10.8K 0.01% 1175
2018
Q1
$2.03M Sell
46,100
-4,577
-9% -$233K 0.01% 1111
2017
Q4
$2.55M Buy
50,677
+6,465
+15% +$355K 0.01% 919
2017
Q3
$2.24M Buy
44,212
+37,083
+520% +$1.94M 0.01% 922
2017
Q2
$363K Sell
7,129
-629
-8% -$29.3K ﹤0.01% 2135
2017
Q1
$299K Sell
7,758
-498
-6% -$22.4K ﹤0.01% 2202
2016
Q4
$391K Sell
8,256
-1,193
-13% -$47.2K ﹤0.01% 1954
2016
Q3
$337K Buy
+9,449
New +$296K ﹤0.01% 2035
2016
Q2
Sell
-20,699
Closed -$880K 2795
2016
Q1
$880K Sell
20,699
-5,991
-22% -$243K ﹤0.01% 1767
2015
Q4
$1.63M Buy
26,690
+13,503
+102% +$729K ﹤0.01% 1311
2015
Q3
$547K Sell
13,187
-12,546
-49% -$649K ﹤0.01% 1708
2015
Q2
$1.43M Buy
25,733
+693
+3% +$44.1K 0.01% 1109
2015
Q1
$1.58M Buy
25,040
+2,835
+13% +$192K 0.01% 1043
2014
Q4
$1.37M Buy
22,205
+761
+4% +$37.6K 0.01% 1096
2014
Q3
$812K Buy
21,444
+6,729
+46% +$238K ﹤0.01% 1417
2014
Q2
$507K Buy
14,715
+2,156
+17% +$67.9K ﹤0.01% 1792
2014
Q1
$543K Buy
12,559
+3,900
+45% +$189K ﹤0.01% 1674
2013
Q4
$345K Buy
+8,659
New +$309K ﹤0.01% 2009

Other funds holding IONS

LPL Financial's IONS Position: Q1 2026 in Review

LPL Financial increased its Ionis Pharmaceuticals (IONS) stake by 2.8% in Q1 2026, buying an estimated $68.1K and bringing the position to 31,932 shares worth $2.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3332.

LPL Financial first reported a position in IONS in Q4 2013 and has held it in 49 quarters since. The position peaked at $4.42M in Q4 2023. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • LPL Financial held 31,932 shares of Ionis Pharmaceuticals worth $2.4M as of Q1 2026.
  • LPL Financial bought 863 Ionis Pharmaceuticals shares in Q1 2026, an estimated $68.1K.
  • Ionis Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #3332 holding.
  • LPL Financial first reported a position in Ionis Pharmaceuticals in Q4 2013 and has held it in 49 quarters since.
  • LPL Financial's Ionis Pharmaceuticals position peaked at $4.42M in Q4 2023.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.